Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

Bone morphogenetic proteins (BMPs) have played a central role in the development of regenerative therapies for bone reconstruction. However, the high cost and side-effect profile of BMPs limits their broad application. Oxysterols, naturally occurring products of cholesterol oxidation, are promising osteogenic agents alternative to BMPs. The osteogenic capacity of these non-toxic and relatively inexpensive molecules has been documented in rodent models. We studied the impact of Oxy49, a novel oxysterol analogue, on the osteogenic differentiation of rabbit bone marrow stromal cells (BMSCs). Moreover, we evaluated the capacity for in vivo bone regeneration with Oxy49 in rabbit cranial bone defects. We found that rabbit BMSCs treated with Oxy49 demonstrated differentiation along osteogenic pathways, and that complete bone regeneration occurred when cranial defects were treated with Oxy49. Collectively, these results demonstrate that Oxy49 has the ability to induce osteogenic differentiation in rabbit BMSCs with an efficacy comparable to that of BMP-2 and to promote significant bone regeneration in cranial defects. Oxysterols may be a viable novel agent in bone tissue engineering. Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2013 John Wiley & Sons, Ltd.


Akishige Hokugo, Sarah Sorice, Farhad Parhami, Anisa Yalom, Andrew Li, Patricia Zuk, Reza Jarrahy. A novel oxysterol promotes bone regeneration in rabbit cranial bone defects. Journal of tissue engineering and regenerative medicine. 2016 Jul;10(7):591-9

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 23997014

View Full Text